- Home
- IFRX vs ARBE Comparison
IFRX vs ARBE Comparison
Compare IFRX & ARBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- ARBE
- Stock Information
- Founded
- IFRX 2007
- ARBE 2015
- Country
- IFRX Germany
- ARBE Israel
- Employees
- IFRX N/A
- ARBE N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- ARBE EDP Services
- Sector
- IFRX Health Care
- ARBE Technology
- Exchange
- IFRX Nasdaq
- ARBE Nasdaq
- Market Cap
- IFRX 117.8M
- ARBE 124.2M
- IPO Year
- IFRX 2017
- ARBE N/A
- Fundamental
- Price
- IFRX $1.00
- ARBE $0.97
- Analyst Decision
- IFRX Strong Buy
- ARBE Buy
- Analyst Count
- IFRX 2
- ARBE 2
- Target Price
- IFRX $9.00
- ARBE $1.75
- AVG Volume (30 Days)
- IFRX 322.6K
- ARBE 2.5M
- Earning Date
- IFRX 05-07-2025
- ARBE 05-21-2025
- Dividend Yield
- IFRX N/A
- ARBE N/A
- EPS Growth
- IFRX N/A
- ARBE N/A
- EPS
- IFRX N/A
- ARBE N/A
- Revenue
- IFRX $171,642.00
- ARBE $768,000.00
- Revenue This Year
- IFRX $106.72
- ARBE $398.05
- Revenue Next Year
- IFRX $66.89
- ARBE $366.67
- P/E Ratio
- IFRX N/A
- ARBE N/A
- Revenue Growth
- IFRX 162.79
- ARBE N/A
- 52 Week Low
- IFRX $1.01
- ARBE $0.97
- 52 Week High
- IFRX $2.82
- ARBE $5.09
- Technical
- Relative Strength Index (RSI)
- IFRX 33.87
- ARBE 24.97
- Support Level
- IFRX $1.01
- ARBE $0.97
- Resistance Level
- IFRX $1.18
- ARBE $1.10
- Average True Range (ATR)
- IFRX 0.12
- ARBE 0.09
- MACD
- IFRX 0.01
- ARBE 0.02
- Stochastic Oscillator
- IFRX 3.66
- ARBE 2.42
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, USA, and others.